Oaktree Acquisition Corp. III Life Sciences (OACC) Equity Average (2025 - 2026)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Equity Average readings, the most recent being -$7.0 million for Q1 2026.

• Quarterly Equity Average fell 11.14% to -$7.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$7.0 million through Mar 2026, down 11.14% year-over-year, with the annual reading at -$6.4 million for FY2025, N/A changed from the prior year.
• Equity Average hit -$7.0 million in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, down from -$6.8 million in the prior quarter.
• Across five years, Equity Average topped out at -$6.3 million in Q1 2025 and bottomed at -$7.0 million in Q1 2026.

Peer Comparison